Algert Global’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,360
| Closed | -$88K | – | 1261 |
|
|
2024
Q4 | $88K | Buy |
+10,360
| New | +$88K | ﹤0.01% | 1126 |
|
|
2023
Q4 | – | Sell |
-23,250
| Closed | -$224K | – | 1191 |
|
|
2023
Q3 | $224K | Sell |
23,250
-3,040
| -12% | -$29.3K | 0.01% | 946 |
|
|
2023
Q2 | $237K | Sell |
26,290
-2,220
| -8% | -$20K | 0.01% | 955 |
|
|
2023
Q1 | $224K | Buy |
+28,510
| New | +$224K | 0.01% | 1009 |
|
|
2021
Q1 | – | Sell |
-12,119
| Closed | -$230K | – | 481 |
|
|
2020
Q4 | $230K | Sell |
12,119
-2,100
| -15% | -$39.9K | 0.07% | 333 |
|
|
2020
Q3 | $179K | Buy |
14,219
+3,090
| +28% | +$38.9K | 0.06% | 325 |
|
|
2020
Q2 | $135K | Sell |
11,129
-7,700
| -41% | -$93.4K | 0.05% | 361 |
|
|
2020
Q1 | $144K | Buy |
18,829
+4,860
| +35% | +$37.2K | 0.06% | 330 |
|
|
2019
Q4 | $249K | Sell |
13,969
-14,767
| -51% | -$263K | 0.07% | 287 |
|
|
2019
Q3 | $333K | Buy |
28,736
+4,069
| +16% | +$47.2K | 0.12% | 202 |
|
|
2019
Q2 | $546K | Buy |
24,667
+8,076
| +49% | +$179K | 0.2% | 161 |
|
|
2019
Q1 | $475K | Sell |
16,591
-2,750
| -14% | -$78.7K | 0.27% | 136 |
|
|
2018
Q4 | $382K | Buy |
+19,341
| New | +$382K | 0.11% | 251 |
|